Kiran Mazumdar-Shaw Expands Access to Life-Saving Drugs
· Business · Bloomberg, Indian Express
Kiran Mazumdar-Shaw founded Biocon from a rented garage nearly 50 years ago, building the enterprise into one of the world's largest producers of insulin. Known as India's Queen of Biotech, she continues to spearhead efforts to make essential medications affordable and accessible to patients globally. Her multibillion-dollar company focuses on biopharmaceuticals, research services, and generic formulations. The report does not specify the current financial figures or upcoming product pipelines for Biocon.
Why it matters
The company's scale directly impacts global access to affordable insulin and critical therapeutics for patients managing diabetes and other chronic conditions.
Read the original report — Bloomberg
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.